The syndromes of reduced sensitivity to thyroid hormone

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 7, 2013, Pages 3987-4003

  Dumitrescu, Alexandra M ^a   Refetoff, Samuel ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Deiodinase; Monocarboxylate transporter 8; Nuclear receptor; Resistance to thyroid hormone; SECIS binding protein 2; Selenoprotein

Indexed keywords

ANTICONVULSIVE AGENT; ATENOLOL; BACLOFEN; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; LEVODOPA; LEVOTHYROXINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; PROPYLTHIOURACIL; SCOPOLAMINE; SELENOMETHIONINE; SELENOPROTEIN; SOMATOSTATIN; THYROID HORMONE; THYROID HORMONE DEIODINASE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROTROPIN; THYROXINE; TIRATRICOL; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; DIFFERENTIAL DIAGNOSIS; DYSTONIA; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE MUTATION; GENETIC MANIPULATION; GENETIC VARIABILITY; GOITER; HUMAN; HYPERSALIVATION; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; LEARNING DISORDER; MEMBRANE TRANSPORT; NONHUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REVIEW; SBP2 GENE; SECISBP2 GENE; SEIZURE; SINUS TACHYCARDIA; THYROID DISEASE; THYROID HORMONE CELL MEMBRANE TRANSPORTER DEFECT; THYROID HORMONE METABOLISM; THYROID HORMONE METABOLISM DEFECT; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; X CHROMOSOME INACTIVATION;

BIOLOGICAL TRANSPORT; HUMANS; MEMBRANE TRANSPORT PROTEINS; MUTATION; PHENOTYPE; RECEPTORS, THYROID HORMONE; THYROID HORMONE RESISTANCE SYNDROME; THYROID HORMONES;

EID: 84877584509     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.08.005     Document Type: Review

References (134)

1. S. Refetoff, L.T. DeWind, and L.J. DeGroot Familial syndrome combining deaf-mutism, stippled epiphyses, goiter, and abnormally high PBI: possible target organ refractoriness to thyroid hormone J. Clin. Endocrinol. Metab. 27 1967 279 294
2. S. Refetoff, L.J. DeGroot, B. Benard, and L.T. DeWind Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone Metabolism 21 1972 723 756
3. C. Weinberger, C.C. Thompson, E.S. Ong, R. Lebo, D.J. Gruol, and R.M. Evans The c-erb-A gene encodes a thyroid hormone receptor Nature 324 1986 641 646
4. J. Sap, A. Munoz, J. Schmitt, H. Stunnenberg, and B. Vennström Repression of transcription mediated at thyroid hormone response element by the v-erbA oncogene product Nature 340 1989 242 244
5. A. Sakurai, K. Takeda, K. Ain, P. Ceccarelli, A. Nakai, S. Seino, G.I. Bell, S. Refetoff, and L.J. DeGroot Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor b Proc. Natl. Acad. Sci. U. S. A. 86 1989 8977 8981
6. A.M. Dumitrescu, X.H. Liao, T.B. Best, K. Brockmann, and S. Refetoff A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene Am. J. Hum. Genet. 74 2004 168 175
7. E.C. Friesema, A. Grueters, H. Biebermann, H. Krude, A. von Moers, M. Reeser, T.G. Barrett, E.E. Mancilla, J. Svensson, M.H. Kester, G.G. Kuiper, S. Balkassmi, A.G. Uitterlinden, J. Koehrle, P. Rodien, A.P. Halestrap, and T.J. Visser Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation Lancet 364 2004 1435 1437
8. A.M. Dumitrescu, X.-H. Liao, S.Y.M. Abdullah, J. Lado-Abeal, F. Abdul-Majed, L.C. Moeller, G. Boran, L. Schomburg, R.E. Weiss, and S. Refetoff Mutations in SECISBP2 result in abnormal thyroid hormone metabolism Nat. Genet. 37 2005 1247 1252
9. S. Refetoff Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone Nat. Clin. Pract. Endocrinol. Metab. 4 2008 1
10. E. Bochukova, N. Schoenmakers, M. Agostini, E. Schoenmakers, O. Rajanayagam, J.M. Keogh, E. Henning, J. Reinemund, E. Gevers, M. Sarri, K. Downes, A. Offiah, A. Albanese, D. Halsall, J.W.R. Schwabe, M. Bain, K. Lindley, F. Muntoni, F. Vargha Khadem, M. Dattani, I.S. Farooqi, M. Gurnell, and K. Chatterjee A mutation in the thyroid hormone receptor alpha gene N. Engl. J. Med. 366 2012 243 249
11. A. van Mullem, R. van Heerebeek, D. Chrysis, E. Visser, M. Medici, M. Andrikoula, A. Tsatsoulis, R. Peeters, and T.J. Visser Clinical phenotype and mutant TRalpha1 N. Engl. J. Med. 366 2012 1451 1453
12. E.C. Friesema, J. Jansen, C. Milici, and T.J. Visser Thyroid hormone transporters Vitam. Horm. 70 2005 137 167
13. A.C. Bianco, D. Salvatore, B. Gereben, M.J. Berry, and P.R. Larsen Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases Endocr. Rev. 23 2002 38 89
14. J.H. Bassett, C.B. Harvey, and G.R. Williams Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions Mol. Cell. Endocrinol. 213 2003 1 11
15. J. Zhang, and M.A. Lazar The mechanism of action of thyroid hormones Annu. Rev. Physiol. 62 2000 439 466
16. P.M. Yen, S. Ando, X. Feng, Y. Liu, P. Maruvada, and X. Xia Thyroid hormone action at the cellular, genomic and target gene levels Mol. Cell. Endocrinol. 246 2006 121 127
17. S. Refetoff, R.E. Weiss, and S.J. Usala The syndromes of resistance to thyroid hormone Endocr. Rev. 14 1993 348 399
18. A.M. Dumitrescu, X.H. Liao, R.E. Weiss, K. Millen, and S. Refetoff Tissue specific thyroid hormone deprivation and excess in Mct8 deficient mice Endocrinology 2006 4036 4043
19. J.D. Fondell, M. Guermah, S. Malik, and R.G. Roeder Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID Proc. Natl. Acad. Sci. U. S. A. 96 1999 1959 1964
20. B.D. Weintraub, M.C. Gershengorn, I.A. Kourides, and H. Fein Inappropriate secretion of thyroid stimulating hormone Ann. Intern. Med. 95 1981 339 351
21. P. Beck-Peccoz, and V.K.K. Chatterjee The variable clinical phenotype in thyroid hormone resistance syndrome Thyroid 4 1994 225 232
22. M.M. Kaplan, S.L. Swartz, and P.R. Larsen Partial peripheral resistance to thyroid hormone Am. J. Med. 70 1981 1115 1121
23. P. Sadow, S. Reutrakul, R.E. Weiss, and S. Refetoff Resistnace to thyroid hormone in the absence of mutations in the thyroid hormone receptor genes Curr. Opin. Endocrinol. Diabetes 7 2000 253 259
24. R.E. Weiss, Y. Hayashi, T. Nagaya, K.J. Petty, Y. Murata, H. Tunka, H. Seo, and S. Refetoff Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptors a or β genes may be due to a defective co-factor J. Clin. Endocrinol. Metab. 81 1996 4196 4203
25. S. Ono, I.D. Schwartz, O.T. Mueller, A.W. Root, S.J. Usala, and B.B. Bercu Homozygosity for a "dominant negative" thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone J. Clin. Endocrinol. Metab. 73 1991 990 994
26. A.M. Ferrara, K. Onigata, O. Ercan, H. Woodhead, R.E. Weiss, and S. Refetoff Homozygous thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: three new cases and review of the literature J. Clin. Endocrinol. Metab. 97 2012 1328 1336
27. P. Hauser, A.J. Zametkin, P. Martinez, B. Vitiello, J.A. Matochik, A.J. Mixson, and B.D. Weintraub Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone N. Engl. J. Med. 328 1993 997 1001
28. R.E. Weiss, M.A. Stein, B. Trommer, and S. Refetoff Attention-deficit hyperactivity disorder and thyroid function J. Pediatr. 123 1993 539 545
29. J. Elia, C. Gulotta, S.R. Rose, G. Martin, and J. Rapoport Thyroid function and attention-deficit hyperactivity disorder J. Am. Acad. Child Adolesc. Psychiatry 33 1994 169 172
30. F. Brucker-Davis, M.C. Skarulis, M.B. Grace, J. Benichou, P. Hauser, E. Wiggs, and B.D. Weintraub Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health prospective study Ann. Intern. Med. 123 1995 573 583
31. S.H. LaFranchi, D.B. Snyder, D.E. Sesser, M.R. Skeels, N. Singh, G.A. Brent, and J.C. Nelson Follow-up of newborns with elevated screening T4 concentrations J. Pediatr. 143 2003 296 301
32. T. Tajima, W. Jo, K. Fujikura, M. Fukushi, and K. Fujieda Elevated free thyroxine levels detected by a neonatal screening system Pediatr. Res. 66 2009 312 316
33. K. Takeda, A. Sakurai, L.J. DeGroot, and S. Refetoff Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-β gene J. Clin. Endocrinol. Metab. 74 1992 49 55
34. T. Mitsuhashi, G.E. Tennyson, and V.M. Nikodem Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormones Proc. Natl. Acad. Sci. U. S. A. 85 1988 5804 5805
35. P.E. Macchia, Y. Takeuchi, T. Kawai, K. Cua, K. Gauthier, O. Chassande, H. Seo, Y. Hayashi, J. Samarut, Y. Murata, R.E. Weiss, and S. Refetoff Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha Proc. Natl. Acad. Sci. U. S. A. 98 2001 349 354
36. K. Gauthier, O. Chassande, M. Platerotti, J.-P. Roux, C. Legrand, B. Rousset, R. Weiss, J. Trouillas, and J. Samarut Different functions for the thyroid hormone receptors TRa and TRβ in the control of thyroid hormone production and post-natal development EMBO J. 18 1999 623 631
37. S. Göthe, Z. Wang, L. Ng, J.M. Kindblom, A. Campos barros, C. Ohlsson, B. Vennström, and D. Forrest Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation Genes Dev. 13 1999 1329 1341
38. R.E. Weiss, M. Weinberg, and S. Refetoff Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene: analysis of 15 families J. Clin. Invest. 91 1993 2408 2415
39. M. Adams, C. Matthews, T.N. Collingwood, Y. Tone, P. Beck-Peccoz, and K.K. Chatterjee Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone: identification of thirteen novel mutations in the thyroid hormone receptor β gene J. Clin. Invest. 94 1994 506 515
40. T.N. Collingwood, R. Wagner, C.H. Matthews, R.J. Clifton-Bligh, G. Mark, O. Rajanayagam, M. Agostini, R.J. Fletterick, P. Beck-Peccoz, W. Reinhardt, G. Binder, M.B. Ranke, A. Hermus, R.D. Hesch, J. Lazarus, N. Paul, V. Parfitt, P. Ragatt, F. de Zegher, and V.K.K. Chatterjee A role for helix 3 of the TRβ ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone EMBO J. 17 1998 4760 4770
41. Y. Hayashi, R.E. Weiss, D.H. Sarne, P.M. Yen, T. Sunthornthepvarakul, C. Marcocci, W.W. Chin, and S. Refetoff Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-β receptors? J. Clin. Endocrinol. Metab. 80 1995 3246 3256
42. 3 receptor and transcriptional corepressor Mol. Endocrinol. 11 1997 470 480
43. B. Gottlieb, H. Lehvaslaiho, L.K. Beitel, R. Lumbroso, L. Pinsky, and M. Trifiro The androgen receptor gene mutations database Nucleic Acids Res. 26 1998 234 238
44. S. Ando, N.J. Sarlis, J. Krishan, X. Feng, S. Refetoff, M.Q. Zhang, E.H. Olfield, and P.M. Yen Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance Mol. Endocrinol. 15 2001 1529 1538
45. S. Ando, N.J. Sarlis, E.H. Oldfield, and P.M. Yen Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor J. Clin. Endocrinol. Metab. 86 2001 5572 5576
46. L. Persani, C. Asteria, M. Tonacchera, P. Vitti, V.K.K. Chatterjee, and P. Beck-Peccoz Evidence for secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance J. Clin. Endocrinol. Metab. 78 1994 1034 1039
47. M.S. Barkoff, M. Kocherginsky, J. Anselmo, R.E. Weiss, and S. Refetoff Autoimmunity in patients with resistance to thyroid hormone J. Clin. Endocrinol. Metab. 95 2010 3189 3193
48. Y. Hayashi, O.E. Janssen, R.E. Weiss, Y. Murata, H. Seo, and S. Refetoff The relative expression of mutant and normal thyroid hormone receptor genes in patients with generalized resistance to thyroid hormone determined by estimation of their specific messenger ribonucleic acid products J. Clin. Endocrinol. Metab. 76 1993 64 69
49. A. Sakurai, T. Miyamoto, S. Refetoff, and L.J. DeGroot Dominant negative transcriptional regulation by a mutant thyroid hormone receptor β in a family with generalized resistance to thyroid hormone Mol. Endocrinol. 4 1990 1988 1994
50. 3)-binding domain of the thyroid hormone receptor (TR) β gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone J. Clin. Invest. 94 1994 607 615
51. I. Jones, M. Srinivas, L. Ng, and D. Forrest The thyroid hormone receptor beta gene: structure and functions in the brain and sensory systems Thyroid 13 2003 1057 1068
52. H. Yagi, J. Pohlenz, Y. Hayashi, A. Sakurai, and S. Refetoff Resistance to thyroid hormone caused by two mutant thyroid hormone receptor β, R243Q and R243W, with marked impairment of function that cannot be explained by altered in-vitro 3,5,3′-triiodothyronine binding affinity J. Clin. Endocrinol. Metab. 82 1997 1608 1614
53. J.D. Safer, R.N. Cohen, A.N. Hollenberg, and F.E. Wondisford Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone J. Biol. Chem. 273 1998 30175 30182
54. R.J. Clifton-Bligh, F. de Zegher, R.L. Wagner, T.N. Collingwood, I. François, M. Van Helvoirt, R.J. Fletterick, and V.K.K. Chatterjee A novel mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation Mol. Endocrinol. 12 1998 609 621
55. S. Lee, B.M. Young, W. Wan, I.H. Chan, and M.L. Privalsky A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR){beta}2 Mol. Endocrinol. 25 2011 1111 1125
56. D.S. Machado, A. Sabet, L.A. Santiago, A.R. Sidhaye, M.I. Chiamolera, T.M. Ortiga-Carvalho, and F.E. Wondisford A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo Proc. Natl. Acad. Sci. U. S. A. 106 2009 9441 9446
57. R.E. Weiss, C. Marcocci, G. Bruno-Bossio, and S. Refetoff Multiple genetic factors in the heterogeneity of thyroid hormone resistance J. Clin. Endocrinol. Metab. 76 1993 257 259
58. A.J. Mixson, P. Hauser, G. Tennyson, J.C. Renault, D.L. Bodenner, and B.D. Weintraub Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone J. Clin. Invest. 91 1993 2296 2300
59. F. Flamant, and J. Samarut Thyroid hormone receptors: lessons from knockout and knock-in mutant mice Trends Endocrinol. Metab. 14 2003 85 90
60. I. Jones, L. Ng, H. Liu, and D. Forrest An intron control region differentially regulates expression of thyroid hormone receptor beta2 in the cochlea, pituitary, and cone photoreceptors Mol. Endocrinol. 21 2007 1108 1119
61. E.D. Abel, M.E. Boers, C. Pazos-Moura, E. Moura, H. Kaulbach, M. Zakaria, B. Lowell, S. Radovick, M.C. Liberman, and F. Wondisford Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system J. Clin. Invest. 104 1999 291 300
62. R.E. Weiss, Y. Murata, K. Cua, Y. Hayashi, H. Seo, and S. Refetoff Thyroid hormone action on liver, heart and energy expenditure in thyroid hormone receptor β deficient mice (Erratum, 141:4767, 2000) Endocrinology 139 1998 4945 4952
63. L. Wikstrom, C. Johansson, C. Salto, C. Barlow, A. Campos Barros, F. Baas, D. Forrest, P. Thoren, and B. Vennstrom Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1 EMBO J. 17 1998 455 461
64. H. Suzuki, M.C. Willingham, and S.Y. Cheng Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis Thyroid 12 2002 963 969
65. L.A. Santiago, D.A. Santiago, L.C. Faustino, A. Cordeiro, P.C. Lisboa, F.E. Wondisford, C.C. Pazos-Moura, and T.M. Ortiga-Carvalho The Delta337T mutation on the TRbeta causes alterations in growth, adiposity, and hepatic glucose homeostasis in mice J. Endocrinol. 211 2011 39 46
66. M. Kaneshige, H. Suzuki, K. Kaneshige, J. Cheng, H. Wimbrow, C. Barlow, M.C. Willingham, and S.-y. Cheng A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 15095 15100
67. A. Tinnikov, K. Nordstrom, P. Thoren, J.M. Kindblom, S. Malin, B. Rozell, M. Adams, O. Rajanayagam, S. Pettersson, C. Ohlsson, K. Chatterjee, and B. Vennstrom Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1 EMBO J. 21 2002 5079 5087
68. Y.Y. Liu, J.J. Schultz, and G.A. Brent A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice J. Biol. Chem. 278 2003 38913 38920
69. F. Flamant, A.L. Poguet, M. Plateroti, O. Chassande, K. Gauthier, N. Streichenberger, A. Mansouri, and J. Samarut Congenital hypothyroid Pax8(-/-) mutant mice can be rescued by inactivating the TRalpha gene Mol. Endocrinol. 16 2002 24 32
70. J. Mittag, S. Friedrichsen, H. Heuer, S. Polsfuss, T.J. Visser, and K. Bauer Athyroid Pax8 -/- mice cannot be rescued by the inactivation of thyroid hormone receptor alpha1 Endocrinology 146 2005 3179 3184
71. B. Morte, J. Manzano, T. Scanlan, B. Vennstrom, and J. Bernal Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism Proc. Natl. Acad. Sci. U. S. A. 99 2002 3985 3989
72. R.E. Weiss, J. Xu, G. Ning, J. Pohlenz, B.W. O'Malley, and S. Refetoff Mice deficient in the steroid receptor coactivator-1 (SRC-1) are resistant to thyroid hormone EMBO J. (Eur. Mol. Biol. Organ.) 18 1999 1900 1904
73. N.S. Brown, A. Smart, V. Sharma, M.L. Brinkmeier, L. Greenlee, S.A. Camper, D.R. Jensen, R.o.H. Eckel, W. Krezel, P. Chambon, and B.R. Haugen Thyroid hormone resistance and increased metabolic rate in the RXR-g-deficient mouse J. Clin. Invest. 106 2000 73 79
74. R. Ekins The free hormone hypothesis and measurement of free hormones Clin. Chem. 38 1992 1289 1293
75. G. Hennemann, R. Docter, E.C. Friesema, M. de Jong, E.P. Krenning, and T.J. Visser Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability Endocr. Rev. 22 2001 451 476
76. E.C. Friesema, S. Ganguly, A. Abdalla, J.E. Manning Fox, A.P. Halestrap, and T.J. Visser Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter J. Biol. Chem. 278 2003 40128 40135
77. K.R. Holden, O.F. Zuniga, M.M. May, H. Su, M.R. Molinero, R.C. Rogers, and C.E. Schwartz X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype J. Child Neurol. 20 2005 852 857
78. C.E. Schwartz, M.M. May, N.J. Carpenter, R.C. Rogers, J. Martin, M.G. Bialer, J. Ward, J. Sanabria, S. Marsa, J.A. Lewis, R. Echeverri, H.A. Lubs, K. Voeller, R.J. Simensen, and R.E. Stevenson Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene Am. J. Hum. Genet. 77 2005 41 53
79. W.E. Visser, J. Jansen, E.C. Friesema, M.H. Kester, E. Mancilla, J. Lundgren, M.S. van der Knaap, R.J. Lunsing, O.F. Brouwer, and T.J. Visser Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations Hum. Mutat. 30 2008 29 38
80. E.C. Friesema, W.E. Visser, and T.J. Visser Genetics and phenomics of thyroid hormone transport by MCT8 Mol. Cell. Endocrinol. 322 2010 107 113
81. K. Brockmann, A.M. Dumitrescu, T.T. Best, F. Hanefeld, and S. Refetoff X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene J. Neurol. 252 2005 663 666
82. L. Boccone, S. Mariotti, V. Dessi, D. Pruna, A. Meloni, and G. Loudianos Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH Eur. J. Med. Genet. 53 2010 392 395
83. W.E. Visser, E.C. Friesema, and T.J. Visser Minireview: thyroid hormone transporters: the knowns and the unknowns Mol. Endocrinol. 25 2011 1 14
84. W. Allan, C.N. Herndon, and F.C. Dudley Some examples of the inheritance of mental deficiency: apparently sex-linked idiocy and microcephaly Am. J. Ment. Defic. 48 1944 325 334
85. H. Biebermann, P. Ambrugger, P. Tarnow, A. von Moers, U. Schweizer, and A. Grueters Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8 Eur. J. Endocrinol. 153 2005 359 366
86. V. Herzovich, E. Vaiani, R. Marino, G. Dratler, J.M. Lazzati, S. Tilitzky, P. Ramirez, S. Iorcansky, M.A. Rivarola, and A. Belgorosky Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene Horm. Res. 67 2006 1 6
87. J.L. Wemeau, M. Pigeyre, E. Proust-Lemoine, M. d'Herbomez, F. Gottrand, J. Jansen, T.J. Visser, and M. Ladsous Beneficial effects of propylthiouracil plus l-thyroxine treatment in a patient with a mutation in MCT8 J. Clin. Endocrinol. Metab. 93 2008 2084 2088
88. S.G. Frints, S. Lenzner, M. Bauters, L.R. Jensen, H. Van Esch, V. des Portes, U. Moog, M.V. Macville, K. van Roozendaal, C.T. Schrander-Stumpel, A. Tzschach, P. Marynen, J.P. Fryns, B. Hamel, H. van Bokhoven, J. Chelly, C. Beldjord, G. Turner, J. Gecz, C. Moraine, M. Raynaud, H.H. Ropers, G. Froyen, and A.W. Kuss MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression Eur. J. Hum. Genet. 16 2008 1029 1037
89. C.E. Schwartz, and R.E. Stevenson The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome Best Pract. Res. Clin. Endocrinol. Metab. 21 2007 307 321
90. A. Papadimitriou, A.M. Dumitrescu, A. Papavasiliou, A. Fretzayas, P. Nicolaidou, and S. Refetoff A novel monocarboxylate transporter 8 gene mutation as a cause of severe neonatal hypotonia and developmental delay Pediatrics 121 2008 e199 e202
91. R.G. Lafreniere, L. Carrel, and H.F. Willard A novel transmembrane transporter encoded by the XPCT gene in Xq13.2 Hum. Mol. Genet. 3 1994 1133 1139
92. A.P. Halestrap, and D. Meredith The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond Pflugers Arch. 447 2004 619 628
93. G. Kleinau, U. Schweizer, A. Kinne, J. Kohrle, A. Gruters, H. Krude, and H. Biebermann Insights into molecular properties of the human monocarboxylate transporter 8 by combining functional with structural information Thyroid Res. 4 Suppl. 1 2011 S4
94. E. Crushell, and W. Reardon Elevated TSH levels in a mentally retarded boy Eur. J. Pediatr. 169 2009 573 575
95. O. Fuchs, N. Pfarr, J. Pohlenz, and H. Schmidt Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutation Dev. Med. Child Neurol. 51 2009 240 244
96. N. Namba, Y. Etani, T. Kitaoka, Y. Nakamoto, M. Nakacho, K. Bessho, Y. Miyoshi, S. Mushiake, I. Mohri, H. Arai, M. Taniike, and K. Ozono Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter Eur. J. Pediatr. 167 2007 785 791
97. C. Vaurs-Barriere, M. Deville, C. Sarret, G. Giraud, V. Des Portes, J.M. Prats-Vinas, G. De Michele, B. Dan, A.F. Brady, O. Boespflug-Tanguy, and R. Touraine Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects Ann. Neurol. 65 2009 114 118
98. A.D. Gika, A. Siddiqui, A.J. Hulse, S. Edwards, P. Fallon, M.E. McEntagart, W. Jan, D. Josifova, T. Lerman-Sagie, J. Drummond, E. Thompson, S. Refetoff, C.G. Bönnemann, and H. Jungbluth White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene Dev. Med. Child Neurol. 52 2010 475 482
99. H. Kakinuma, M. Itoh, and H. Takahashi A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid J. Pediatr. 147 2005 552 554
100. P.E. Sijens, L.A. Rodiger, L.C. Meiners, and R.J. Lunsing 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency J. Clin. Endocrinol. Metab. 93 2008 1854 1859
101. M. Trajkovic, T.J. Visser, J. Mittag, S. Horn, J. Lukas, V.M. Darras, G. Raivich, K. Bauer, and H. Heuer Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8 J. Clin. Invest. 117 2007 627 635
102. J. Bernal Role of monocarboxylate anion transporter 8 (MCT8) in thyroid hormone transport: answers from mice Endocrinology 147 2006 4034 4035
103. M. Trajkovic-Arsic, J. Muller, V.M. Darras, C. Groba, S. Lee, D. Weih, K. Bauer, T.J. Visser, and H. Heuer Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice Endocrinology 151 2010 5053 5062
104. C. Di Cosmo, X.H. Liao, A.M. Dumitrescu, N.J. Philp, R.E. Weiss, and S. Refetoff Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion J. Clin. Invest. 120 2010 3377 3388
105. X.H. Liao, C. Di Cosmo, A.M. Dumitrescu, A. Hernandez, J. Van Sande, D.L. St Germain, R.E. Weiss, V.A. Galton, and S. Refetoff Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes Endocrinology 152 2011 1180 1191
106. E. Fliers, U.A. Unmehopa, and A. Alkemade Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland Mol. Cell. Endocrinol. 251 2006 1 8
107. C. Di Cosmo, X.H. Liao, A.M. Dumitrescu, R.E. Weiss, and S. Refetoff A thyroid hormone analogue with reduced dependence on the monocarboxylate transporter 8 (MCT8) for tissue transport Endocrinology 150 2009 4450 4458
108. D.M. Driscoll, and P.R. Copeland Mechanism and regulation of selenoprotein synthesis Annu. Rev. Nutr. 23 2003 17 40
109. R.J. Koenig Regulation of type 1 iodothyronine deiodinase in health and disease Thyroid 15 2005 835 840
110. C. Di Cosmo, N. McLellan, X.H. Liao, K.K. Khanna, R.E. Weiss, L. Papp, and S. Refetoff Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X) J. Clin. Endocrinol. Metab. 94 2009 4003 4009
111. M.F. Azevedo, G.B. Barra, L.A. Naves, L.F. Ribeiro Velasco, P. Godoy Garcia Castro, L.C. de Castro, A.A. Amato, A. Miniard, D. Driscoll, L. Schomburg, and F. de Assis Rocha Neves Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene J. Clin. Endocrinol. Metab. 95 2010 4066 4071
112. E. Schoenmakers, M. Agostini, C. Mitchell, N. Schoenmakers, L. Papp, O. Rajanayagam, R. Padidela, L. Ceron-Gutierrez, R. Doffinger, C. Prevosto, J. Luan, S. Montano, J. Lu, M. Castanet, N. Clemons, M. Groeneveld, P. Castets, M. Karbaschi, S. Aitken, A. Dixon, J. Williams, I. Campi, M. Blount, H. Burton, F. Muntoni, D. O'Donovan, A. Dean, A. Warren, C. Brierley, D. Baguley, P. Guicheney, R. Fitzgerald, A. Coles, H. Gaston, P. Todd, A. Holmgren, K.K. Khanna, M. Cooke, R. Semple, D. Halsall, N. Wareham, J. Schwabe, L. Grasso, P. Beck-Peccoz, A. Ogunko, M. Dattani, M. Gurnell, and K. Chatterjee Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans J. Clin. Invest. 120 2010 4220 4235
113. T. Hamajima, Y. Mushimoto, H. Kobayashi, Y. Saito, and K. Onigata Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation Eur. J. Endocrinol. 166 2012 757 764
114. A. Lescure, C. Allmang, K. Yamada, P. Carbon, and A. Krol cDNA cloning, expression pattern and RNA binding analysis of human selenocysteine insertion sequence (SECIS) binding protein 2 Gene 291 2002 279 285
115. P.R. Copeland Regulation of gene expression by stop codon recoding: selenocysteine Gene 312 2003 17 25
116. L.V. Papp, J. Lu, F. Striebel, D. Kennedy, A. Holmgren, and K.K. Khanna The redox state of SECIS binding protein 2 controls its localization and selenocysteine incorporation function Mol. Cell. Biol. 26 2006 4895 4910
117. A. Dumitrescu, C. Di Cosmo, X.H. Liao, R. Weiss, and S. Refetoff The syndrome of inherited partial SBP2 deficiency in humans Antioxid. Redox Signal. 12 2010 905 920
118. J.L. Bubenik, and D.M. Driscoll Altered RNA-binding activity underlies abnormal thyroid hormone metabolism linked to a mutation in Sec insertion sequence binding protein 2 J. Biol. Chem. 282 2007 34653 34662
119. G.V. Kryukov, S. Castellano, S.V. Novoselov, A.V. Lobanov, O. Zehtab, R. Guigo, and V.N. Gladyshev Characterization of mammalian selenoproteomes Science 300 2003 1439 1443
120. L.V. Papp, J. Lu, A. Holmgren, and K.K. Khanna From selenium to selenoproteins: synthesis, identity, and their role in human health Antioxid. Redox Signal. 9 2007 775 806
121. M.R. Bosl, K. Takaku, M. Oshima, S. Nishimura, and M.M. Taketo Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp) Proc. Natl. Acad. Sci. U. S. A. 94 1997 5531 5534
122. M.J. Schneider, S.N. Fiering, B. Thai, S.Y. Wu, E. St Germain, A.F. Parlow, D.L. St Germain, and V.A. Galton Targeted disruption of the type 1 selenodeiodinase gene (dio1) results in marked changes in thyroid hormone economy in mice Endocrinology 147 2006 580 589
123. M.J. Schneider, S.N. Fiering, S.E. Pallud, A.F. Parlow, D.L. St Germain, and V.A. Galton Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T(4) Mol. Endocrinol. 15 2001 2137 2148
124. A. Hernandez, M.E. Martinez, S. Fiering, V.A. Galton, and D. St Germain Type 3 deiodinase is critical for the maturation and function of the thyroid axis J. Clin. Invest. 116 2006 476 484
125. L. Ng, R.J. Goodyear, C.A. Woods, M.J. Schneider, E. Diamond, G.P. Richardson, M.W. Kelley, D.L. Germain, V.A. Galton, and D. Forrest Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase Proc. Natl. Acad. Sci. U. S. A. 101 2004 3474 3479
126. S.Y. Wu, R.N. Cohen, E. Simsek, D.A. Senses, N.E. Yar, H. Grasberger, J. Noel, S. Refetoff, and R.E. Weiss A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone J. Clin. Endocrinol. Metab. 91 2006 1887 1895
127. P. Iglesias, and J.J. Diez Therapeutic possibilities in patients with selective pituitary resistance to thyroid hormones Med. Clin. (Barc) 130 2008 345 350
128. P. Beck-Peccoz, G. Piscitelli, M.G. Cattaneo, and G. Faglia Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3′-triiodothyroacetic acid (TRIAC) J. Endocrinol. Invest. 6 1983 217 223
129. G. Radetti, L. Persani, G. Molinaro, D. Mannavola, D. Cortelazzi, V.K.K. Chatterjee, and P. Beck-Peccoz Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance Thyroid 7 1997 775 778
130. T. Takeda, S. Suzuki, R.-T. Liu, and L.J. DeGroot Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone J. Clin. Endocrinol. Metab. 80 1995 2033 2040
131. J. Anselmo, D. Cao, T. Karrison, R.E. Weiss, and S. Refetoff Fetal loss associated with excess thyroid hormone exposure JAMA 292 2004 691 695
132. J. Anselmo, and S. Refetoff Regression of a large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine Thyroid 14 2004 71 74
133. L. Schomburg, A.M. Dumitrescu, X.H. Liao, B. Bin-Abbas, J. Hoeflich, J. Kohrle, and S. Refetoff Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations Thyroid 19 2009 277 281
134. P. Beck-Peccoz, V.K.K. Chatterjee, W.W. Chin, L.J. DeGroot, J.L. Jameson, H. Nakamura, S. Refetoff, S.J. Usala, and B.D. Weintraub Nomenclature of thyroid hormone receptor β-gene mutations in resistance to thyroid hormone: Consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom J. Clin. Endocrinol. Metab. 78 1993 990 993